Mcf Advisors LLC Care Dx, Inc. Transaction History
Mcf Advisors LLC
- $1.38 Billion
- Q1 2025
A detailed history of Mcf Advisors LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Mcf Advisors LLC holds 340 shares of CDNA stock, worth $5,157. This represents 0.0% of its overall portfolio holdings.
Number of Shares
340
Previous 270
25.93%
Holding current value
$5,157
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CDNA
# of Institutions
223Shares Held
54MCall Options Held
53.5KPut Options Held
23.9K-
Black Rock Inc. New York, NY5.29MShares$80.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.86MShares$73.7 Million0.0% of portfolio
-
State Street Corp Boston, MA2.66MShares$40.3 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.35MShares$35.6 Million0.45% of portfolio
-
Bamco Inc New York, NY2.21MShares$33.5 Million0.13% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $811M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...